Mirtazapine Impurity 4 | CAS 23174-98-3 - Request Quote
Mirtazapine Impurity 4
| SZ CAT No: | SZ-M027020 |
| CAS No | 23174-98-3 |
| Mol.F. | C18H22N2 |
| Mol.Wt. | 266.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 577955-33-0 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mirtazapine Impurity 4 is chemically 1-Benzyl-4-methyl-2-phenylpiperazine. Mirtazapine Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Mirtazapine Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirtazapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 23174-98-3
Purchase 23174-98-3
Order 23174-98-3
Enquire 23174-98-3
price of 23174-98-3
23174-98-3 Supplier
23174-98-3 Manufacturer
23174-98-3 Exporter
buy high quality Mirtazapine Impurity 4
Purchase Mirtazapine Impurity 4
Mirtazapine Impurity 4 suppliers
Mirtazapine Impurity 4 manufacturers
Mirtazapine Impurity 4 price
Order Mirtazapine Impurity 4
Enquire Mirtazapine Impurity 4
Mirtazapine Impurity 4 cost
Mirtazapine Impurity 4 Supplier
Mirtazapine Impurity 4 Distributor
Mirtazapine Impurity 4 for Method Validation
Mirtazapine Reference Standard
Mirtazapine Impurity 4 for ANDA Filing
Mirtazapine Impurity 4 for Forced Degradation Studies
Mirtazapine Impurity 4 Identification Standards
Mirtazapine Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.